IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Glenmark Pharmaceuticals LT INR 1.0

CUSIP: Y2711C144 | 1 institutional holders

Quarters

Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2024

Stanley-Laman Group, Ltd.150,000
0.2% of portfolio›$1.7M
StyleTurnoverLocationFiled
Stanley-Laman Group, Ltd.
150,000$1.7M0.2%CoreMediumBerwyn, PA2024-04-17